Skip to main content
. Author manuscript; available in PMC: 2018 Jun 12.
Published in final edited form as: J Cereb Blood Flow Metab. 2008 Mar 5;28(6):1104–1113. doi: 10.1038/jcbfm.2008.4

Figure 1.

Figure 1

Identification of BrdU-positive cells. (A, B) Immunohistochemistry after tolerance. (A) DAPI staining. (B) BrdU staining of cells at the ipsilateral subependymal zone (25 μm from the margin of the ventricle in adult brain considered as subependymal zone). (C) BrdU-positive cells at the subependymal zone of control group. (D) Subependymal zone BrdU immunoreactivity was significantly decreased after MAM treatment. (E) BrdU immunostaining more prominent on the ipsilateral side of the brain (right) (CC, −0.50±0.20 mm from bregma) after tolerance induction. (F) Panels A and B merged. Brain sections in panels A–D were obtained from 0.50±0.20 mm from bregma. The insets in panels C and D (c and d) are magnified and presented on the right. v: ventricle. Bars: 100 μm.